Glenn S Boehnlein Stryker Corp (SYK) insider trading activity

Glenn S Boehnlein is VP, Chief Financial Officer of STRYKER CORP. Currently has a direct ownership of 5,128 shares of SYK, which is worth approximately $2 Million. The most recent transaction as insider was on Jan 11, 2023, when has been sold 14,515 shares (Common Stock) at a price of $64.01 per share, resulting in proceeds of $929,105. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 5.13K

79.8% 3M change

82.79% 12M change

Total Value Held $2 Million

Glenn S Boehnlein Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 11 2023	BUY Exercise of conversion of derivative security	$929,105 $64.01 p/Share	14,515 Added 29.15%	35,286 Common Stock
May 01 2022	SELL Payment of exercise price or tax liability	$138,001 $241.26 p/Share	572 Reduced 3.02%	18,350 Common Stock
May 01 2022	BUY Exercise of conversion of derivative security	-	1,210 Added 6.01%	18,922 Common Stock
Mar 21 2022	SELL Payment of exercise price or tax liability	$1,100,371 $267.34 p/Share	4,116 Reduced 18.86%	17,712 Common Stock
Mar 21 2022	BUY Exercise of conversion of derivative security	-	8,723 Added 28.55%	21,828 Common Stock
Dec 21 2021	SELL Payment of exercise price or tax liability	$42,121 $247.77 p/Share	170 Reduced 1.28%	13,105 Common Stock
Dec 21 2021	BUY Exercise of conversion of derivative security	-	170 Added 1.26%	13,275 Common Stock
Dec 10 2021	SELL Open market or private sale	$721,752 $259.81 p/Share	2,778 Reduced 17.49%	13,105 Common Stock
Mar 21 2021	SELL Payment of exercise price or tax liability	$652,970 $230.0 p/Share	2,839 Reduced 15.16%	15,883 Common Stock
Mar 21 2021	BUY Grant, award, or other acquisition	-	6,401 Added 25.48%	18,722 Common Stock
Mar 01 2021	SELL Open market or private sale	$492,020 $246.01 p/Share	2,000 Reduced 13.97%	12,321 Common Stock
Dec 28 2020	SELL Open market or private sale	$478,200 $239.1 p/Share	2,000 Reduced 12.25%	14,321 Common Stock

Also insider at

INGN

Inogen Inc Healthcare

GSB